What are the benefits of including external data in the design and analysis of clinical studies?
How does the meta-analytic predictive model (MAP) work?

Boosting clinical trial data with external data belongs to the very hot topics at the moment. Every conference includes a session about it and many webinars present about it. I’m very happy to have an expert in this area on the show – Gaëlle Saint-Hilary. Learn, when is it appropriate to use historical data and when is it appropriate to enrol new patients to collect new data.

Gaëlle and I talked about the various topics around using historical data in clinical trials:
  • What is dynamic borrowing?
  • What are the impacts on sample size and effective sample size?
  • How do we best make decisions based on the final results?

Listen to this episode and share this with your friends and colleagues!

Never miss an episode!

Join thousends of your peers and subscribe to get our latest updates by email!

Get the shownotes of our podcast episodes plus tips and tricks to increase your impact at work to boost your career!

We won’t send you spam. Unsubscribe at any time. Powered by ConvertKit

Learn on demand

Click on the button to see our Teachble Inc. cources.

Load content

Gaëlle Saint-Hilary

CEO, Statistical Methodologist at Saryga

Gaëlle Saint-Hilary is Statistical Methodologist, CEO and founder of the consulting company Saryga (France). Before this role, Gaëlle was Statistical Methodologist at Servier until December 2021. With more than 15 years of experience in the pharmaceutical industry (Servier, Novartis) and a strong and long-lasting collaboration with academia, Gaëlle Saint-Hilary is an expert in Bayesian statistics and decision-making support. She has worked at developing novel approaches to improve drug development’s performances, and her main scientific interests are quantitative decision-making, benefit-risk assessment, innovative study designs and historical data.

 

Join The Effective Statistician LinkedIn group

I want to help the community of statisticians, data scientists, programmers and other quantitative scientists to be more influential, innovative, and effective. I believe that as a community we can help our research, our regulatory and payer systems, and ultimately physicians and patients take better decisions based on better evidence.

I work to achieve a future in which everyone can access the right evidence in the right format at the right time to make sound decisions.

When my kids are sick, I want to have good evidence to discuss with the physician about the different therapy choices.

When my mother is sick, I want her to understand the evidence and being able to understand it.

When I get sick, I want to find evidence that I can trust and that helps me to have meaningful discussions with my healthcare professionals.

I want to live in a world, where the media reports correctly about medical evidence and in which society distinguishes between fake evidence and real evidence.

Let’s work together to achieve this.